BIIB
Biogen (BIIB)
NASDAQ
$216.80-$0.35 (-0.16%)
Price as of Sep 11, 2026 7:30 PM EDT
  • $32.1B
    Market Cap
  • 49.90%
    1-Year Change
  • Drug Manufacturers - General
    Industry

Earnings Score

Score: 42
Valuation
BIIB
vs History
vs S&P 500
Profitability
-0
Growth
-1
Low Earnings Volatility
0

Momentum Score

Score: 58
Valuation
BIIB
vs History
vs S&P 500
3-Month Momentum
4.91%
12-Month Momentum
40.33%
3-Month Risk Adjusted Momentum
27.51%
12-Month Risk Adjusted Momentum
118.36%

True Yield

N/A
Valuation
BIIB
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
N/A
Net Debt Paydown Yield
-4.06%

Financial Health Score

Score: 15
Valuation
BIIB
vs History
vs S&P 500
Ohlson's O-Score
8